Search Within

Achim Jungbluth

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (39)
  2. Meeting Abstract (27)
Groups
  1. Department of Pathology and Laboratory Medicine (66)
  2. Human Oncology and Pathogenesis Program (66)
  3. GSK Faculty (65)
  4. Tow Center for Developmental Oncology (TCDO) (54)
  5. Department of Medicine (44)
  6. Solid Tumor Oncology Division (40)

More Groups

People
  1. Marc Ladanyi (51)
  2. Denise Frosina (26)
  3. Cristina Antonescu (21)
  4. Ryma Benayed (20)
  5. Natasha Rekhtman (13)
  6. Sarah Chiang (11)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (1)
  4. 2022 (5)
  5. 2021 (6)
  6. 2020 (8)

More Years

Publications
  1. Modern Pathology (23)
  2. Laboratory Investigation (9)
  3. American Journal of Surgical Pathology (6)
  4. Clinical Cancer Research (4)
  5. Journal of Thoracic Oncology (3)
  6. Cancer Discovery (2)

More Publications

Publishers
  1. Nature Research (23)
  2. Nature Publishing Group (12)
  3. American Association for Cancer Research (7)
  4. Lippincott Williams & Wilkins (6)
  5. Elsevier Inc. (5)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (66)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparison of MTAP immunohistochemistry (IHC) with p16/CDKN2A deletions/loss and utility of MTAP and BAP1 IHC in the diagnosis of malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Shahi, M.; Eguchi, T.; Zauderer, M.; Travis, W.; Jungbluth, A.; Frosina, D.; Fayad, M.; Asher, M.; Adusumilli, P. S.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • ZC3H7B-BCOR high-grade endometrial stromal sarcomas: A report of 17 cases of a newly defined entity
    Meeting Abstract

    Lewis, N.; Soslow, R.; DeLair, D.; Park, K.; Murali, R.; Hollmann, T.; Davidson, B.; Micci, F.; Panagopoulos, I.; Hoang, L.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Novel PLAG1 gene rearrangement distinguishes uterine myxoid leiomyosarcoma from other uterine myxoid mesenchymal tumors
    Meeting Abstract

    Arias-Stella, J. A.; Lewis, N.; Benayed, R.; Oliva, E.; Young, R.; Hoang, L.; Lee, C. H.; Soslow, R.; Antonescu, C. R.; Ladanyi, M.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma
    Meeting Abstract

    Chiang, S.; Cotzia, P.; Hyman, D.; Drilon, A.; Hechtman, J.; Jungbluth, A.; Murali, R.; Soslow, R.; Oliva, E.; Benayed, R.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • SETD2 mutation Is a recurrent secondary alteration in synovial sarcoma associated with loss of the H3k36me3 histone mark
    Meeting Abstract

    Tai, H.; Ito, T.; Jungbluth, A.; Ladanyi, M.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • ZC3H7B-BCOR high-grade endometrial stromal sarcomas: A report of 17 cases of a newly defined entity
    Journal Article

    Lewis, N.; Soslow, R. A.; Delair, D. F.; Park, K. J.; Murali, R.; Hollmann, T. J.; Davidson, B.; Micci, F.; Panagopoulos, I.; Hoang, L. N.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Estrogen receptor-negative breast adenomyoepitheliomas are driven by co-occurring HRAS hotspot and PI3K pathway gene mutations: A genetic and functional analysis
    Meeting Abstract

    Geyer, F. C.; Li, A.; Papanastasiou, A. D.; Smith, A.; Selenica, P.; Burke, K. A.; Edelweiss, M.; Wen, H. C.; Piscuoglio, S.; Schultheis, A. M.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing
    Meeting Abstract

    Fan, P. D.; Narzisi, G.; Jayaprakash, A.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Jordan, E.; Wang, L.; Jungbluth, A. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Pan-TRK immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions
    Journal Article

    Hechtman, J. F.; Benayed, R.; Hyman, D. M.; Drilon, A.; Zehir, A.; Frosina, D.; Arcila, M. E.; Dogan, S.; Klimstra, D. S.; Ladanyi, M.; more...
    American Journal of Surgical Pathology (2017)

    Fulltext@MSK | Save
  • BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology
    Journal Article

    Chiang, S.; Lee, C. H.; Stewart, C. J. R.; Oliva, E.; Hoang, L. N.; Ali, R. H.; Hensley, M. L.; Arias-Stella, J. A. 3rd; Frosina, D.; Jungbluth, A. A.; more...
    Modern Pathology (2017)

    Fulltext@MSK | Save